US Patent Issued to EPICENTRX on July 16 for "Multiple transgene recombinant adenovirus" (California Inventors)

  • Christopher Larson

Press/Media

Period17 Jul 2024

Media coverage

1

Media coverage

  • TitleUS Patent Issued to EPICENTRX on July 16 for "Multiple transgene recombinant adenovirus" (California Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date17/07/24
    PersonsChristopher Larson
View all 1
View less